In 2011, our group reported that GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), two native incretins, elicited anti-atherogenic effects in apolipoprotein-E-null (Apoe−/−) mice, an animal model of atherosclerosis [9]. Here, GLP1R is linked to atherosclerosis.